Literature DB >> 23125177

Avidity-mediated virus separation using a hyperthermophilic affinity ligand.

Mahmud Hussain1, Dustin Lockney, Ruqi Wang, Nimish Gera, Balaji M Rao.   

Abstract

Immunoaffinity separation of large multivalent species such as viruses is limited by the stringent elution conditions necessary to overcome their strong and highly avid interaction with immobilized affinity ligands on the capture surface. Here we present an alternate strategy that harnesses the avidity effect to overcome this limitation. Red clover necrotic mosaic virus (RCNMV), a plant virus relevant to drug delivery applications, was chosen as a model target for this study. An RCNMV binding protein (RBP) with modest binding affinity (K(D) ~100 nM) was generated through mutagenesis of the Sso7d protein from Sulfolobus solfataricus and used as the affinity ligand. In our separation scheme, RCNMV is captured by a highly avid interaction with RBP immobilized on a nickel surface through a hexahistidine (6xHis) tag. Subsequently, disruption of the multivalent interaction and release of RCNMV is achieved by elution of RBP from the nickel surface. Finally, RCNMV is separated from RBP by exploiting the large difference in their molecular weights (~8 MDa vs. ~10 kDa). Our strategy not only eliminates the need for harsh elution conditions, but also bypasses chemical conjugation of the affinity ligand to the capture surface. Stable non-antibody affinity ligands to a wide spectrum of targets can be generated through mutagenesis of Sso7d and other hyperthermophilic proteins. Therefore, our approach may be broadly relevant to cases where capture of large multivalent species from complex mixtures and subsequent release without the use of harsh elution conditions is necessary.
Copyright © 2012 American Institute of Chemical Engineers (AIChE).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125177     DOI: 10.1002/btpr.1655

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  8 in total

1.  Inefficient Ribosomal Skipping Enables Simultaneous Secretion and Display of Proteins in Saccharomyces cerevisiae.

Authors:  Carlos A Cruz-Teran; Karthik Tiruthani; Adam Mischler; Balaji M Rao
Journal:  ACS Synth Biol       Date:  2017-08-14       Impact factor: 5.110

2.  Engineering a Protein Binder Specific for p38α with Interface Expansion.

Authors:  Mahmud Hussain; Steven P Angus; Brian Kuhlman
Journal:  Biochemistry       Date:  2018-07-19       Impact factor: 3.162

3.  Activity-based assessment of an engineered hyperthermophilic protein as a capture agent in paper-based diagnostic tests.

Authors:  E A Miller; M W Traxlmayr; J Shen; H D Sikes
Journal:  Mol Syst Des Eng       Date:  2016-06-29

4.  Generation of Thermally Stable Affinity Pairs for Sensitive, Specific Immunoassays.

Authors:  Elliot Corless; Yining Hao; Huan Jia; Patthara Kongsuphol; Dousabel M Y Tay; Say Yong Ng; Hadley D Sikes
Journal:  Methods Mol Biol       Date:  2022

5.  A Fyn biosensor reveals pulsatile, spatially localized kinase activity and signaling crosstalk in live mammalian cells.

Authors:  Ananya Mukherjee; Randhir Singh; Sreeram Udayan; Sayan Biswas; Pothula Purushotham Reddy; Saumya Manmadhan; Geen George; Shilpa Kumar; Ranabir Das; Balaji M Rao; Akash Gulyani
Journal:  Elife       Date:  2020-02-04       Impact factor: 8.140

6.  Design and evaluation of engineered protein biosensors for live-cell imaging of EGFR phosphorylation.

Authors:  Karthik Tiruthani; Adam Mischler; Shoeb Ahmed; Jessica Mahinthakumar; Jason M Haugh; Balaji M Rao
Journal:  Sci Signal       Date:  2019-06-04       Impact factor: 8.192

Review 7.  Artificial affinity proteins as ligands of immunoglobulins.

Authors:  Barbara Mouratou; Ghislaine Béhar; Frédéric Pecorari
Journal:  Biomolecules       Date:  2015-01-30

8.  Use of the Nanofitin Alternative Scaffold as a GFP-Ready Fusion Tag.

Authors:  Simon Huet; Harmony Gorre; Anaëlle Perrocheau; Justine Picot; Mathieu Cinier
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.